Anti-STIM1/ D11S4896E/ GOK monoclonal antibody
Anti-STIM1/ D11S4896E/ GOK antibody for FACS & in-vivo assay
Go to STIM1/STIM1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-MP1716-Ab-1/ GM-Tg-hg-MP1716-Ab-2 | Anti-Human STIM1 monoclonal antibody | Human |
GM-Tg-rg-MP1716-Ab-1/ GM-Tg-rg-MP1716-Ab-2 | Anti-Rat STIM1 monoclonal antibody | Rat |
GM-Tg-mg-MP1716-Ab-1/ GM-Tg-mg-MP1716-Ab-2 | Anti-Mouse STIM1 monoclonal antibody | Mouse |
GM-Tg-cynog-MP1716-Ab-1/ GM-Tg-cynog-MP1716-Ab-2 | Anti-Cynomolgus/ Rhesus macaque STIM1 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-MP1716-Ab-1/ GM-Tg-felg-MP1716-Ab-2 | Anti-Feline STIM1 monoclonal antibody | Feline |
GM-Tg-cang-MP1716-Ab-1/ GM-Tg-cang-MP1716-Ab-2 | Anti-Canine STIM1 monoclonal antibody | Canine |
GM-Tg-bovg-MP1716-Ab-1/ GM-Tg-bovg-MP1716-Ab-2 | Anti-Bovine STIM1 monoclonal antibody | Bovine |
GM-Tg-equg-MP1716-Ab-1/ GM-Tg-equg-MP1716-Ab-2 | Anti-Equine STIM1 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-MP1716-Ab-1/ GM-Tg-hg-MP1716-Ab-2; GM-Tg-rg-MP1716-Ab-1/ GM-Tg-rg-MP1716-Ab-2; GM-Tg-mg-MP1716-Ab-1/ GM-Tg-mg-MP1716-Ab-2; GM-Tg-cynog-MP1716-Ab-1/ GM-Tg-cynog-MP1716-Ab-2; GM-Tg-felg-MP1716-Ab-1/ GM-Tg-felg-MP1716-Ab-2; GM-Tg-cang-MP1716-Ab-1/ GM-Tg-cang-MP1716-Ab-2; GM-Tg-bovg-MP1716-Ab-1/ GM-Tg-bovg-MP1716-Ab-2; GM-Tg-equg-MP1716-Ab-1/ GM-Tg-equg-MP1716-Ab-2 |
Products Name | Anti-STIM1 monoclonal antibody |
Format | mab |
Target Name | STIM1 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-STIM1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species STIM1/ D11S4896E/ GOK VLP (virus-like particle) (Products Developing) |
ORF Viral Vector | vGMLP001315 | human STIM1 Lentivirus particle |
ORF Viral Vector | pGMLP001315 | human STIM1 Lentivirus plasmid |
ORF Viral Vector | pGMAD000647 | Norway rat Stim1 Adenovirus plasmid |
ORF Viral Vector | pGMLPm004111 | mouse Stim1 Lentivirus plasmid |
ORF Viral Vector | vGMAD000647 | Norway rat Stim1 Adenovirus particle |
ORF Viral Vector | vGMLPm004111 | mouse Stim1 Lentivirus particle |
Target information
Target ID | GM-MP1716 |
Target Name | STIM1 |
Gene ID | 6786,20866,361618,717963,608643,101087780,534816,100053079 |
Gene Symbol and Synonyms | D11S4896E,GOK,IMD10,SIM,STIM1,STRMK,TAM,TAM1 |
Uniprot Accession | Q13586,P84903,Q58CP9 |
Uniprot Entry Name | STIM1_HUMAN,STIM1_RAT,STIM1_BOVIN |
Protein Sub-location | Transmembrane Protein |
Category | |
Disease | Cancer |
Gene Ensembl | ENSG00000167323 |
Target Classification | Tumor-associated antigen (TAA) |
The target: STIM1, gene name: STIM1, also named as D11S4896E, GOK, IMD10, STRMK, TAM, TAM1. This gene encodes a type 1 transmembrane protein that mediates Ca2+ influx after depletion of intracellular Ca2+ stores by gating of store-operated Ca2+ influx channels (SOCs). It is one of several genes located in the imprinted gene domain of 11p15.5, an important tumor-suppressor gene region. Alterations in this region have been associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocrotical carcinoma, and lung, ovarian, and breast cancer. This gene may play a role in malignancies and disease that involve this region, as well as early hematopoiesis, by mediating attachment to stromal cells. Mutations in this gene are associated with fatal classic Kaposi sarcoma, immunodeficiency due to defects in store-operated calcium entry (SOCE) in fibroblasts, ectodermal dysplasia and tubular aggregate myopathy. This gene is oriented in a head-to-tail configuration with the ribonucleotide reductase 1 gene (RRM1), with the 3' end of this gene situated 1.6 kb from the 5' end of the RRM1 gene. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.